Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Morphine in Cardiac Surgeries
NCT02825056Phase 1Unknown
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Jul 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of morphine in valvular heart disease (VHD) and coronary artery disease (CAD) (2 arms), sponsored by Post Graduate Institute of Medical Education and Research. Primary endpoint: Incidence of Vasoplegia at 48 hours. Status: unknown.
02
Drugs
morphine
03
Conditions
valvular heart disease (VHD)coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02825056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02825056.